Feasibility and usefulness of brain imaging in catatonia

Magnat, Maeva; Mastellari, Tomas; Krystal, Sidney; Hanafi, Riyad; Mateos, Marjorie; Hacein‐Bey, Lotfi; Haroche, Aurélie; Rogers, Jonathan; Williams, S. C.; Pruvo, Jean‐Pierre; Amad, Ali

doi:10.1016/j.jpsychires.2022.11.003

Cited by 4 publications

(2 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A systematic review of structural and functional brain imaging in catatonia, which identified 137 case reports and 18 studies with multiple patients (pooled n = 186), found that more than 75% of cases of catatonia were associated with non-focal brain imaging abnormalities affecting several brain regions, and associated with a variety of underlying conditions, including neuroinflammatory conditions (SLE, encephalitis) ( Haroche et al, 2020 ). The most common abnormalities in catatonia are generalised atrophy and non-specific white matter abnormalities ( Haroche et al, 2020 ; Jeyaventhan et al, 2022 ; Magnat et al, 2022 ).…”

Section: Clinical Assessmentmentioning

confidence: 99%

“…In terms of focal neurological lesions in catatonia, there are case reports of catatonia associated with lesions to the frontal, parietal and temporal lobes, basal ganglia, diencephalon and cerebellum and lesions around the third ventricle. However, larger studies have found that most of the structural neuroimaging abnormalities in catatonia consist of generalised atrophy or non-specific white matter abnormalities ( Jeyaventhan et al, 2022 ; Magnat et al, 2022 ).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology

et al. 2023

View full text Add to dashboard Cite

The British Association for Psychopharmacology developed an evidence-based consensus guideline on the management of catatonia. A group of international experts from a wide range of disciplines was assembled. Evidence was gathered from existing systematic reviews and the primary literature. Recommendations were made on the basis of this evidence and were graded in terms of their strength. The guideline initially covers the diagnosis, aetiology, clinical features and descriptive epidemiology of catatonia. Clinical assessments, including history, physical examination and investigations are then considered. Treatment with benzodiazepines, electroconvulsive therapy and other pharmacological and neuromodulatory therapies is covered. Special regard is given to periodic catatonia, malignant catatonia, neuroleptic malignant syndrome and antipsychotic-induced catatonia. There is attention to the needs of particular groups, namely children and adolescents, older adults, women in the perinatal period, people with autism spectrum disorder and those with certain medical conditions. Clinical trials were uncommon, and the recommendations in this guideline are mainly informed by small observational studies, case series and case reports, which highlights the need for randomised controlled trials and prospective cohort studies in this area.

show abstract